Synthesis and Properties of 1,3-Disubstituted Ureas and Their Isosteric Analogues Containing Polycyclic Fragments. XVII. 1-[(3-Bromadamantan-1-yl)]-3-R-Ureas and Symmetric Diureas

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

A series of 1,3-disubstituted ureas and diureas was synthesized by the reaction of (3-bromoadamantan-1-yl)isocyanate with aliphatic diamines, fluorine-containing anilines, and trans-4-amino-(cyclohexyloxy)benzoic acid in 36–85% yields. Hydrolysis of (3-bromoadamantan-1-yl)isocyanate in the presence of catalytic amounts of DBU afforded symmetrical 1,3-bis-((3-bromadamantan-1-yl)urea in 60% yield. are promising inhibitors of human soluble epoxide hydrolase hsEH.

Толық мәтін

Рұқсат жабық

Авторлар туралы

B. Gladkikh

Volgograd state technical university (VSTU)

Хат алмасуға жауапты Автор.
Email: butov@post.volpi.ru
ORCID iD: 0000-0001-6271-0479
Ресей, Volgograd

V. D’yachenko

Volgograd state technical university (VSTU)

Email: butov@post.volpi.ru
Ресей, Volgograd

D. Danilov

Volgograd state technical university (VSTU)

Email: butov@post.volpi.ru
ORCID iD: 0000-0001-8734-2617
Ресей, Volgograd

A. Matyukhina

Institute of General and Inorganic Chemistry. N.S. Kurnakov RAS

Email: butov@post.volpi.ru
ORCID iD: 0000-0002-2831-6838
Ресей, Moscow

V. Burmistrov

Volgograd state technical university (VSTU)

Email: butov@post.volpi.ru
ORCID iD: 0000-0002-8547-9166
Ресей, Volgograd

G. Butov

Volgograd state technical university (VSTU); Volzhsky polytechnic institute (branch) VSTU

Email: butov@post.volpi.ru
Ресей, Volgograd; Volzhsky

Әдебиет тізімі

  1. Данилов Д.В., Дьяченко В.С., Бурмистров В.В., Бутов Г.М. ЖОрХ, 2022, 58 (11), 1135–1144. [Danilov D.V., D’yachenko V.S., Burmistrov V.V., Butov G.M. Russ. J. Org. Chem. 2022, 58 (11), 1561-1568.] doi. 10.31857/S0514749222110015
  2. Niu Tianyu, Zhao Xiaoqiang, Jiang Jing, Yan Haiyan, Li Yinghong, Tang Sheng, Li Yuhuan, Song Danqing Molecules. 2019, 24 (5), 921. doi: 10.3390/molecules24050921
  3. Park Jin-Hee, Lee Ga-Eun, Lee So-Deok, Hien Tran Thi, Kim Sujin, Yang Jin Won, Cho Joong-Heui, Kang Keon-Wook, Kim Yong-Chul. J. Med.Chem. 2015, 58 (5), 2114–2134. doi: 10.1021/jm2012326
  4. Telfer T.J., Liddell J.R., Duncan C., White A.R., Codd R. Bioorg. Med. Chem. Lett. 2017, 27 (8), 1698 – 1704. doi: 10.1016/j.bmcl.2017.03.001
  5. Hwang S.H., Wecksler A.T., Zhang G., Morisseau C., Nguyen L.V., Fu S.H., Hammock B.D., Bioorg. Med. Chem. Lett. 2013, 23, 3732–3737. doi: 10.1016/j.bmcl.2013.05.011
  6. Wagner K.M., McReynolds C.B., Schmidt W.K., Hammock B.D. Pharmacol. Ther. 2017, 180, 62–76. doi: 10.1016/j.pharmthera.2017.06.006
  7. Inceoglu B., Jinks S.L., Ulu A., Hegedus C.M., Georgi K., Schmelzer K.R., Wagner K., Jones P.D., Morisseau C., Hammock B.D. Proc. Natl. Acad. Sci. 2008, 105, 18901–18906. doi: 10.1073/pnas.0809765105
  8. Fleming I., Rueben A., Popp R., Fisslthaler B., Schrodt S., Sander A., Haendeler J., Falck J.R., Morisseau C., Hammock B.D., Busse R. Arterioscler. ThrombVasc. Biol. 2007, 27, 2612–2618. doi: 10.1161/ATVBAHA.107.152074
  9. Burmistrov V.V., Morisseau C., Harris T.R., Butov G.M., Hammock B.D. Bioorg. Chem. 2018, 76, 510–527. doi: 10.1016/j.bioorg.2017.12.024
  10. Moiseev I.K., Doroshenko R.I., Mratkhuzina T.A., Novikov S.S., USSR Chem. Bull. 1973, 22, 51–54. doi: 10.1007/bf00854113
  11. Burmistrov V., Morisseau C., Lee K.S.S., Shihadih D.S., Harris T.R., Butov G.M., Hammock B.D., Bioorg. Med. Chem. Lett., 2014, 24, 2193. doi: 10.1016/j.bmcl.2014.03.016
  12. Hwang S.H., Wecksler A.T., Zhang G., Morisseau C., Nguyen L.V., Fu S.H., Hammock B.D. Bioorg. Med. Chem. Lett. 2013, 23, 3732. doi: 10.1016/j.bmcl.2013.05.011
  13. Бутов Г.М., Бурмистров В.В., Дьяченко В.С., ЖОрХ, 2017, 53, 965–968. [Butov G.M., Burmistrov V.V., D’yachenko V.S., Russ. J. Org. Chem., 2017, 53, 977–980.] doi: 10.1134/S107042801707003X
  14. Гладких Б.П., Данилов Д.В., Дьяченко В.С., Бурмистров В.В., Бутов Г.М., Новаков И.А. Изв. АН сер. хим. 2022, 9, 1998–2005. [Gladkikh B.P., Danilov D.V., D’yachenko V.S., Burmistrov V.V., Butov G.M., Novakov I.A. Russ. Chem. Bull. (Engl. Transl.), 2022, 9, 1998–2005.] doi: 10.1007/s11172-022-3620-1
  15. Sheldrick G.M., SADABS. Program for Empirical X-ray Absorption Correction, Bruker-Nonius, 1990–2004.
  16. Sheldrick, G.M. Acta Cryst. 2008, A64, 112–122. doi.10.1107/S0108767307043930
  17. Sheldrick, G.M. Acta Cryst. 2015, A71, 3–8. doi: 10.1107/S2053273314026370
  18. Dolomanov O.V., Bourhis L.J., Gildea R.J. J. Appl. Cryst. 2009, 42, 339–341. doi: 10.1107/S0021889808042726

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Fig. 1. Compounds containing 3-bromoadamantyl fragment possessing biological activity

Жүктеу (88KB)
Метадеректер
3. Fig. 2. ORTEP diagram showing the anisotropic displacement ellipsoids of non-hydrogen atoms with a probability of 50% for compound 4k according to the X-ray diffraction data of a single crystal collected at 100 K.

Жүктеу (78KB)
Метадеректер
4. Fig. 3. Dependence of the melting point of halogenated diureas 4a–i on the number of methylene groups n: 1 – F-Ad-(diurea) [14]; 2 – Br-Ad-(diurea); 3 – Cl-Ad-(diurea) [9]

Жүктеу (98KB)
Метадеректер
5. Scheme 1

Жүктеу (44KB)
Метадеректер
6. Scheme 2

Жүктеу (190KB)
Метадеректер
7. Scheme 3

Жүктеу (121KB)
Метадеректер

© Russian Academy of Sciences, 2024